[1]肖晴,黄文祥,章述军,等.人参皂苷Rg1激活腺苷酸激活蛋白激酶抑制体外诱导的非酒精性脂肪性肝细胞模型脂质沉积[J].第三军医大学学报,2019,41(14):1343-1349.
 XIAO Qing,HUANG Wenxiang,ZHANG Shujun,et al.Ginsenoside Rg1 activates AMPK to inhibit lipid deposition in a cell model of non-alcoholic fatty liver disease[J].J Third Mil Med Univ,2019,41(14):1343-1349.
点击复制

人参皂苷Rg1激活腺苷酸激活蛋白激酶抑制体外诱导的非酒精性脂肪性肝细胞模型脂质沉积
(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
41卷
期数:
2019年第14期
页码:
1343-1349
栏目:
基础医学
出版日期:
2019-07-30

文章信息/Info

Title:
Ginsenoside Rg1 activates AMPK to inhibit lipid deposition in a cell model of non-alcoholic fatty liver disease
作者:
重庆医科大学附属第一医院感染科
Author(s):
XIAO Qing HUANG Wenxiang ZHANG Shujun YANG Cheng LI Jiajun ZHAO Jinqiu GAO Yue
Department of Infectious Diseases, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China 
关键词:
非酒精性脂肪性肝病人参皂苷Rg1脂质沉积腺苷酸活化蛋白激酶
Keywords:
non-alcoholic fatty liver disease ginsenoside Rg1 lipid deposition AMP-activated protein kinase 
分类号:
R282.71;R285.5;R575.505
文献标志码:
A
摘要:

目的 探讨人参皂苷Rg1对非酒精性脂肪性肝细胞模型脂质沉积的作用及其分子机制。方法 用0.25 mmol/L棕榈酸处理HepG2细胞24 h构建非酒精性脂肪肝细胞模型;加或不加10 μmol/L AMPK抑制剂(Compound C,CC)预处理1 h,再使用40 μg/mL人参皂苷Rg1或5 μmol/L二甲双胍处理6 h。微量法检测细胞内甘油三酯(triglyceride, TG)含量;油红O染色观察脂滴聚集情况。RT-qPCR及Western blot检测腺苷酸激活蛋白激酶(AMP-activated protein kinase,AMPK)通路相关基因及蛋白的变化。结果 与对照组比较,模型组细胞内TG、油红O染色吸光度增加(P<005)。Rg1能减少TG及油红O染色吸光度(P<005)。Rg1能增加被棕榈酸抑制的腺苷酸激活蛋白激酶(AMPK)和乙酰辅酶A羧化酶(acetyl-CoA carboxylase,ACC)的磷酸化,下调胆固醇结合调节元件蛋白(sterol regulatory element binding proteins-1c,SREBP-1C)和脂肪酸合成酶(fatty acid synthase,FAS)的表达(P<005),CC预处理能显著逆转Rg1的改善作用及其对AMPK通路的影响(P<005)。结论 Rg1可通过调控腺苷酸激活蛋白激酶通路减少非酒精性脂肪性肝病细胞模型脂质沉积.

Abstract:

Objective To investigate the effect of ginsenoside Rg1 on lipid deposition in a cell model of non-alcoholic fatty liver disease (NAFLD) and explore the molecular mechanism. MethodsHepG2 cells were treated with 0.25 mmol/L palmitic acid for 24 h to induce changes mimicking NAFLD, followed by treatment with 40 μg/mL ginsenoside Rg1 or 5 μmol/L metformin for 6 h with or without pretreatment with 10 μmol/L Compound C (CC, an AMPK inhibitor) for 1 h. The level of triglyceride (TG) in the cells was detected using a micromethod, and the accumulation of lipid droplets was observed using Oil Red O staining. RT-qPCR and Western blotting were employed to detect the alterations in the mRNA and protein expression of the key genes related to the AMPK pathway. ResultsCompared with the control cells, the cell model of NAFLD showed significantly increased intracellular TG level and lipid droplet accumulation (P<005), which were both reduced obviously after Rg1 treatment (P<005). Rg1 significantly abolished palmitic acid-induced inhibition of phosphorylation of intracellular AMPK and acetyl-CoA carboxylase (ACC), and down-regulated the expression of sterol regulatory element-binding protein-1c and fatty acid synthase (P<005). Pretreatment with CC significantly antagonized the effects of Rg1 on intracellular TG, lipid deposition and AMPK pathway in palmitic acid-induced cells (P<005). ConclusionGinsenoside Rg1 can ameliorate lipid deposition in the cell model of NAFLD by activating the AMPK pathway.

相似文献/References:

[1]王萍,周玥,王亚平,等.人参皂苷Rg1促进人牙周膜干细胞增殖与成骨分化[J].第三军医大学学报,2013,35(15):1566.
 Wang Ping,Zhou Yue,Wang Yaping,et al.Promotion of ginsenoside Rg1 on proliferation and osteogenic potential of human periodontal ligament stem cells[J].J Third Mil Med Univ,2013,35(14):1566.
[2]杨万兴.补益口服液中人参皂苷Rg1的含量测定方法[J].第三军医大学学报,2003,25(24):0.[doi:10.16016/j.1000-5404.2003.24.033 ]
[3]王恬然,聂志强,邹灏,等.人参皂苷Rg1促进移植大鼠的组织工程血管内皮化[J].第三军医大学学报,2020,42(05):444.
 WANG Tianran,NIE Zhiqiang,ZOU Hao,et al.Ginsenoside Rg1 promotes endothelialization of tissue-engineered blood vessels in transplanted rats[J].J Third Mil Med Univ,2020,42(14):444.

更新日期/Last Update: 2019-07-22